Antidiabetics - GEN - Genetic Engineering and Biotechnology News

Antidiabetics

Faulty “Dimmer Switch” in Diabetes Can Be Repaired

Antidiabetics

Sanofi, Hanmi Ink Up-to-$4.2B Long-Acting Diabetes Drug Alliance

Antidiabetics

Sanofi, Lexicon Partner to Develop Phase III Diabetes Drug

Antidiabetics

Hanmi, Janssen Launch Up-to-$915M+ Diabetes/Obesity Alliance

Antidiabetics

Sanofi Ends Afrezza Collaboration with MannKind

Finger being pricked for diabetes test

Antidiabetics

Findings Point to a Novel Approach to the Treatment of Diabetes

Antidiabetics

Hitachi Chemical Agrees $75M Deal for Caladrius Cell Therapy Manufacturer, PCT

Antidiabetics

Mouse Model May Offer Novel Insights for Treating Obesity and Type...

Alzheimer's disease

Antidiabetics

Triple-Acting Diabetes Drug Reverses Memory Loss in Alzheimer’s Disease Mouse Models

Antidiabetics

Wiping Out Zombie Cells in Fat May Delay or Alleviate Diabetes

Antidiabetics

Smart Insulin for Diabetes Therapy Could Protect against Hypoglycemia

Computer artwork of DNA (deoxyribonucleic acid) molecule and red blood cells

Antidiabetics

miRNA Downregulation in Red Blood Cells Causes Vascular Damage in Type...

Antidiabetics

T1D Patients Benefit from Blood Pressure Drug in Two-Year Study

Novo Nordisk

Antidiabetics

Intervening in Beta Cell-Immune System Dialogue Could Prevent Diabetes, Study Suggests